Well the AI is really raining on my parade today! Lets hope its confidently incorrect on that front (not that I expect a drug tomorrow, nice as that would be...)
It's weird though, I searched the preprint for drug, treatment and theraputic and only really found this phase claiming that the...
And, it seems, large meticulous genetic studies can be ignored also. Facinating what it's possible to ignore if your faith in the almighty psychobehavioral paradigm is strong enough. Almost inspiring.
Yes I think they are trying to hold back the tide by painting this study as much more insignificant than it is, saying 'well we are still light years away from having any idea what is causing this' etc...
Understood. I certainly didn't think this gene was a definite slam dunk, just something that maybe strengthened the argument for JEs hypothesis. I hadn't realised that the IFNG/CD8 T CellI element was just from that one mouse model paper though.
It would be interesting if we could come up with...
It has a certain appeal! It sounds like something from an old sci fi film.
This does all look rather relevant to your hypothesis, unless I'm very much mistaken?
Does anyone have an opinion where the best place to donate currently is? Like through AfME or directly to Chris Ponting's lab? I understand the final pieces on finalising this study will be done by Chris and a small team on limited funding so maybe that is the best place to donate initally? Or...
As we discussed in the preprint thread, the fact this is downregulated and it inhibits CD8 T cells and IFNG might be relevant to JE et al's hypothesis and related theorising.
Maybe i should reply on bluesky but LDN and Baricitinib are already being thoroughly trialed (although I guess LDN is being trialed in ME). GLP1 is an interesting idea I suppose, not sure what the rationale is. As for SGB, I am really skeptical, but I suppose it's better to have a trial than not...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.